Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HIV adherence check: can a blood test predict viral control?

NCT ID NCT05335590

First seen Mar 15, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study followed 384 people with HIV who were already taking the medication TAF. Researchers wanted to see if measuring drug levels in dried blood spots could predict whether the virus stays suppressed. Participants had up to 3 visits over 48 weeks. The goal was to better understand how medication adherence relates to viral control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Colorado Health

    Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.